Cargando…

Gender disparity in the survival of patients with primary myelodysplastic syndrome

Several prognostic scoring systems have been developed to assess prognosis in myelodysplastic syndrome (MDS). However, currently there are no systems that list gender as a prognostic factor. We queried a National Cancer Institute database to investigate the prognostic influence of gender on the surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fangfang, Ni, Jun, Wu, Lei, Wang, Ying, He, Bin, Yu, Duonan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400681/ https://www.ncbi.nlm.nih.gov/pubmed/30854142 http://dx.doi.org/10.7150/jca.28220

Ejemplares similares

Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes
por: Sotirova, Tatjana, et al.
Publicado: (2014)

Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
por: Montalban-Bravo, Guillermo, et al.
Publicado: (2018)

Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival
por: Li, Wang-Zhong, et al.
Publicado: (2021)

Gender, nutritional disparities, and child survival in Nepal
por: Fledderjohann, Jasmine, et al.
Publicado: (2022)

B lymphocytes transdifferentiate into immunosuppressive erythroblast-like cells
por: Yang, Zhe, et al.
Publicado: (2023)

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
por: Chen, Ying, et al.
Publicado: (2023)

Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes
por: Dong, Wen, et al.
Publicado: (2016)

A Primary Care Approach to Myelodysplastic Syndromes
por: Samiev, Djamshed, et al.
Publicado: (2014)

EASIX for prediction of survival in lower-risk myelodysplastic syndromes
por: Merz, Almuth, et al.
Publicado: (2019)

Platelet response during the second cycle of decitabine treatment predicts response and survival for myelodysplastic syndrome patients
por: Jung, Hyun Ae, et al.
Publicado: (2015)

Impact of the COVID-19 pandemic on gender disparities in acute coronary syndrome patterns
por: Yendrapalli, Usha, et al.
Publicado: (2022)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
por: Malcovati, Luca, et al.
Publicado: (2011)

Contextualizing gender disparities in online teaching evaluations for professors
por: Zheng, Xiang, et al.
Publicado: (2023)

Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes
por: Shiseki, Masayuki, et al.
Publicado: (2019)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
por: Elnahass, Yasser, et al.
Publicado: (2018)

The Academic Advantage: Gender Disparities in Patenting
por: Sugimoto, Cassidy R., et al.
Publicado: (2015)

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing
por: Xu, Yuanyuan, et al.
Publicado: (2017)

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment
por: Gangat, N, et al.
Publicado: (2016)

Hypomethylation of MIR‐378 5’‐flanking region predicts poor survival in young patients with myelodysplastic syndrome
por: Wu, De‐hong, et al.
Publicado: (2019)

Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors
por: Yue, Yingxing, et al.
Publicado: (2014)

The French-American-British classification of myelodysplastic syndromes
por: Mittelman, Moshe
Publicado: (2023)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

COVID-19 and gender disparities: Labour market outcomes
por: Singh, Vikkram, et al.
Publicado: (2022)

Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
por: Qin, Taichun, et al.
Publicado: (2011)

Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes
por: Maurya, Nehakumari, et al.
Publicado: (2022)

Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome
por: Han, Yu, et al.
Publicado: (2016)

TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes
por: McGraw, Kathy L., et al.
Publicado: (2015)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes()
por: Vu, Minh Phuong, et al.
Publicado: (2022)

Gender Disparities and Outcomes Of Acute Coronary Syndromes In Brazil
por: Lorenzo, Andrea De
Publicado: (2018)

Sex‐gender disparities in nonagenarians with acute coronary syndrome
por: Cepas‐Guillen, Pedro L., et al.
Publicado: (2021)

Myelodysplastic syndromes and overlap syndromes
por: Chang, Yoon Hwan
Publicado: (2021)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Myelodysplastic Syndromes and Metabolism
por: Balaian, Ekaterina, et al.
Publicado: (2021)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Somatic mutations predict outcomes of hypomethylating therapy in patients with myelodysplastic syndrome
por: Jung, Seung-Hyun, et al.
Publicado: (2016)

Reduced miR-16 levels are associated with VEGF upregulation in high-risk myelodysplastic syndromes
por: Xiong, Bei, et al.
Publicado: (2021)

Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
por: Zhao, Youshan, et al.
Publicado: (2022)

Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
por: Merrill, Andrea L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sks3vo0hdca54n1i64khk7930p